Showing 309 results

Filters Content type: News, Editors' picks, About HIV Topic: TB treatment

Active tuberculosis (TB) disease is treated with a combination of antibiotics. Successful treatment usually requires at least six months of therapy, without missing doses. People living with HIV also need to take HIV treatment, but it may be started a few weeks after TB treatment. Care is needed when taking TB and HIV treatment at the same time.

TB treatment

The key to overcoming the dual burden of TB and HIV

Editor's pick
Devex
24 November 2023
Access to healthcare

TAG Reacts to J&J Commitment to Not Enforce Patents on Bedaquiline

Editor's pick
Treatment Action Group
3 October 2023
Drug-resistant TB

Johnson & Johnson drops secondary patents for bedaquiline

Editor's pick
CIDRAP
3 October 2023
Tuberculosis & HIV

Very poor long-term outcomes for people with TB and HIV in Eastern Europe

News
29 September 2023
Access to healthcare

Unprecedented TB Drugs Stock-Out in India: Union Health Minister Skips UN High-Level Meet

Editor's pick
The Wire
25 September 2023
TB treatment

Historic Price Reductions up to 55% for Bedaquiline, a Life-Saving Drug to Treat Drug-Resistant TB

Editor's pick
Stop TB Partnership
7 September 2023
TB treatment

Once-daily dolutegravir sufficient when taking TB treatment

News
16 June 2023
Tuberculosis & HIV

CROI 2023 Tuberculosis Research Round Up

Editor's pick
Treatment Action Group
8 March 2023
TB treatment

India: With daily injections and two years of costly treatment, TB survivors look for a ray of light

Editor's pick
Indian Express
16 January 2023
Drug-resistant TB

WHO announces landmark changes in treatment of drug-resistant tuberculosis

Editor's pick
World Health Organization
19 December 2022
TB treatment

Response to TB treatment trials results published and presented during the 2022 Union World Conference on Lung Health

Editor's pick
TAG
22 November 2022
TB treatment

TB treatment can be cut to two months for some, finds landmark study

Editor's pick
Spotlight
17 November 2022
Drug-resistant TB

Shorter Treatment Regimen for Drug-Resistant TB is More Effective

Editor's pick
Health Policy Watch
9 November 2022
TB treatment

South Africa to expedite TB diagnosis/treatment as cases continue to soar

Editor's pick
Medical Brief
22 September 2022
TB treatment

A Breakthrough Tuberculosis Treatment Just Got Safer

Editor's pick
Health Policy Watch
2 September 2022
Low CD4 count

What will it take to end advanced HIV disease-related deaths?

News
8 August 2022
Drug-resistant TB

Treatment Success Likely for Multidrug-Resistant Tuberculosis During Pregnancy

Editor's pick
Infectious Disease Advisor
21 July 2022
Drug-resistant TB

Shorter, simpler DR-TB regimen expected later this year

Editor's pick
Spotlight
22 June 2022
Tuberculosis & HIV

Starting ART Early Essential to Battling Not 1, but 2 Killers

Editor's pick
Infectious Disease Special Edition
16 May 2022
Drug-resistant TB

Rapid communication: Key changes to the treatment of drug-resistant tuberculosis

Editor's pick
World Health Organization
4 May 2022
Health problems in children & young people

TB Treatment Can Be Shortened for Most Children: Study

Editor's pick
Medscape (requires free registration)
10 March 2022
TB treatment

CDC recommends 4-month regimen for drug-susceptible TB

Editor's pick
Healio
7 March 2022
Drug-resistant TB

Fewer Pills Plus Shorter Time: New Way to Control Drug-Resistant TB?

Editor's pick
MedPage Today
21 February 2022
Drug-resistant TB

EXCELLENT NEWS: MSF TB-PRACTECAL clinical trial finds short, effective and safe drug-resistant tuberculosis treatment

Editor's pick
MSF
20 October 2021